DapuStor revenue and financials
In the fiscal year ended December 2025, DapuStor reported revenue of ¥2.29B (+137.87% year over year). The net loss was ¥480.67M.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +137.87%
- 2025 vs 2024
- Net margin
- -21.0%
- 2024: -19.8%
How DapuStor is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 60.2% a year on average over the last 3 years
Compound annual growth rate: from ¥556.77M in 2022 to ¥2.29B in 2025.
Operating margin rose from −93.5% to −20.7%
Operating income over revenue, 2022 → 2025: 72.8 percentage points.
Profitable in 0 of 4 fiscal years
Positive net income, fiscal years 2022–2025.
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 2,289 | 962 | 519 | 557 |
| Cost of revenue | 2,230 | 751 | 783 | 652 |
| Gross profit | 59.2 | 211 | -263 | -95.4 |
| Selling, general and administrative | 138 | 101 | 108 | 253 |
| Research and development | 385 | 274 | 269 | 194 |
| Operating income | -473 | -165 | -617 | -521 |
| EBIT | -473 | -165 | -617 | -521 |
| EBITDA | -461 | -154 | -608 | -514 |
| Interest expense | 20.3 | 12.7 | 3.9 | 6.9 |
| Pre-tax income | -481 | -191 | -617 | -534 |
| Net income | -481 | -191 | -617 | -534 |
| Net income to common shareholders | -481 | -191 | -617 | -534 |
| Basic EPS | -1.22 | -0.49 | -1.71 | — |
| Diluted EPS | -1.22 | -0.49 | -1.71 | — |
| Average shares (basic) | 394 | 389 | 361 | — |
| Average shares (diluted) | 394 | 389 | 361 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 3,413 | 1,310 | 770 | 770 | 451 | 297 |
| Cost of revenue | 2,297 | 818 | 658 | 658 | 633 | 281 |
| Gross profit | 1,115 | 492 | 112 | 112 | -182 | 16.3 |
| Selling, general and administrative | 44.5 | 30.3 | 42.3 | 42.3 | 30.4 | 22.7 |
| Research and development | 102 | 76.3 | 126 | 126 | 62.8 | 69.9 |
| Operating income | 954 | 386 | -59.4 | -59.4 | -266 | -81.2 |
| EBIT | 954 | 386 | -59.4 | -59.4 | -266 | -81.2 |
| EBITDA | 958 | 389 | -58.3 | -58.3 | -265 | -78.6 |
| Interest expense | 7.9 | 7.7 | 6.8 | 6.8 | 3.1 | 3.6 |
| Pre-tax income | 970 | 370 | -63.6 | -63.6 | -230 | -124 |
| Income tax | 6.0 | — | — | — | -0.0 | 0.0 |
| Net income | 964 | 370 | -63.5 | -63.5 | -230 | -124 |
| Net income to common shareholders | 964 | 370 | -63.5 | -63.5 | -230 | -124 |
| Basic EPS | 2.30 | 0.94 | -0.16 | -0.16 | -0.58 | -0.32 |
| Diluted EPS | 2.30 | 0.94 | -0.16 | -0.16 | -0.58 | -0.32 |
| Average shares (basic) | 420 | 394 | 395 | 395 | 399 | 387 |
| Average shares (diluted) | 420 | 394 | 395 | 395 | 399 | 387 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 2,899 | 1,883 | 770 | 793 |
| Current assets | 2,720 | 1,750 | 666 | 709 |
| Cash and equivalents | 253 | 311 | 129 | 223 |
| Short-term investments | 10.9 | 10.6 | 11.0 | — |
| Receivables | 894 | 218 | 248 | 95.6 |
| Inventory | 1,447 | 1,062 | 234 | 318 |
| Net property, plant and equipment | 112 | 88.8 | 80.6 | 60.3 |
| Other intangible assets | 14.6 | 1.9 | 1.6 | 1.0 |
| Long-term investments | 16.4 | 16.3 | 4.7 | — |
| Current liabilities | 2,390 | 1,051 | 351 | 451 |
| Accounts payable | 1,400 | 758 | 193 | 225 |
| Long-term debt | 77.0 | — | — | — |
| Total debt | 915 | 210 | 66.6 | 173 |
| Total liabilities | 2,483 | 1,074 | 360 | 461 |
| Total equity (incl. minority) | 416 | 810 | 410 | 332 |
| Retained earnings | -1,071 | -591 | -400 | -990 |
| Minority interest | -0.6 | -0.2 | — | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total assets | 7,545 | 3,717 | 2,899 | 2,899 | 1,981 | — |
| Current assets | 7,324 | 3,539 | 2,720 | 2,720 | 1,825 | — |
| Cash and equivalents | 1,849 | 523 | 253 | 253 | 271 | — |
| Short-term investments | — | — | 10.9 | 10.9 | 10.8 | — |
| Receivables | 2,091 | 924 | 894 | 894 | 475 | — |
| Inventory | 3,007 | 1,959 | 1,447 | 1,447 | 984 | — |
| Net property, plant and equipment | 121 | 111 | 112 | 112 | 89.3 | — |
| Other intangible assets | 45.3 | 14.4 | 14.6 | 14.6 | 14.6 | — |
| Long-term investments | 22.7 | 17.8 | 16.4 | 16.4 | 15.8 | — |
| Current liabilities | 3,810 | 2,839 | 2,390 | 2,390 | 1,463 | — |
| Accounts payable | 2,191 | 1,894 | 1,400 | 1,400 | 865 | — |
| Long-term debt | 58.2 | 60.0 | 77.0 | 77.0 | 19.0 | — |
| Total debt | 1,563 | 948 | 915 | — | 588 | — |
| Total liabilities | 3,899 | 2,916 | 2,483 | 2,483 | 1,500 | — |
| Total equity (incl. minority) | 3,645 | 801 | 416 | 416 | 481 | 810 |
| Retained earnings | 263 | -702 | -1,071 | -1,071 | -945 | — |
| Minority interest | -0.8 | -0.7 | -0.6 | -0.6 | -0.2 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -878 | -560 | -530 | -322 |
| Depreciation and amortization | 19.9 | 19.2 | 15.4 | 12.3 |
| Capital expenditure | -52.0 | -29.6 | -23.4 | -56.8 |
| Investing cash flow | -51.9 | -38.6 | -37.4 | -15.5 |
| Financing cash flow | 875 | 686 | 517 | 367 |
| Dividends paid | -12.2 | -4.6 | -3.7 | -5.0 |
| Debt issued | 916 | 200 | 50.0 | 222 |
| Debt repaid | -159 | -159 | -168 | -100 |
| Effect of exchange rates | -4.3 | 0.8 | -0.4 | 0.0 |
| Net change in cash | -59.1 | 88.0 | -50.6 | 29.6 |
| Free cash flow | -930 | -589 | -553 | -379 |
| Levered free cash flow | -547 | -400 | -362 | — |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1,170 | 299 | -209 | -209 | 3.6 | -465 |
| Depreciation and amortization | 11.5 | — | 4.9 | 4.9 | 10.2 | — |
| Capital expenditure | -16.2 | -10.0 | -14.8 | -14.8 | -20.3 | -2.2 |
| Investing cash flow | -16.2 | -0.5 | -14.8 | -14.8 | -20.2 | -2.1 |
| Financing cash flow | 2,535 | 43.4 | 193 | 193 | 160 | 329 |
| Dividends paid | -5.8 | -5.4 | -4.2 | -4.2 | -1.6 | -2.2 |
| Share repurchases | — | — | — | — | -0.4 | — |
| Debt issued | 978 | 271 | 222 | 222 | 306 | 302 |
| Debt repaid | -246 | -274 | -29.2 | -29.2 | -43.1 | -62.1 |
| Effect of exchange rates | 5.2 | -3.1 | -1.9 | -1.9 | -0.4 | -0.2 |
| Net change in cash | 1,355 | 339 | -32.0 | -32.0 | 143 | -138 |
| Free cash flow | -1,186 | 289 | -223 | -223 | -16.7 | -467 |
| Levered free cash flow | -1,474 | 64.8 | -12.2 | — | — | — |
Financial statements of similar companies
Companies in the group: same industry, similar size